Prévisions du marché européen du traitement de la sarcopénie jusqu\'en 2030 – Analyse régionale – par type de traitement (supplément de vitamine D et de calcium, supplément de protéines, supplément de vitamine B12 et autres) et canal de distribution (pharmacies, canaux de vente au détail, canaux en ligne et autres)

BMIRE00030430 | Pages: 78 | Pharmaceuticals | Jul 2024 | Type: Regional | Status: Published
Le marché européen du traitement de la sarcopénie était évalué à 993,46 millions de dollars US en 2022 et devrait atteindre 1 467,81 millions de dollars US d’ici 2030 ; on estime qu\'il enregistrera un TCAC de 5,0 % de 2022 à 2030.

L\'augmentation de la malnutrition et des carences en vitamines chez les adultes stimule le marché européen du traitement de la sarcopénie

La malnutrition est l\'un des principaux facteurs de risque de la sarcopénie. . Selon l’OMS, environ 2,3 milliards d’adultes dans le monde souffraient de sous-alimentation en 2021, ce qui représente près de 30 % de la population mondiale. Parmi les facteurs de risque rapportés, le déficit protéino-énergétique est une cause fréquente de sarcopénie. De plus, une carence ou une insuffisance en vitamine D est positivement associée à un risque accru de maladies multiples, telles que le cancer, l’obésité, les maladies cardiovasculaires et la sarcopénie. Selon les National Institutes of Health (NIH), près de 50 % de la population mondiale souffre d’une insuffisance en vitamine D, et environ 1 milliard de personnes souffrent d’une carence en vitamine D.

Aperçu du marché européen du traitement de la sarcopénie

Le marché européen du traitement de la sarcopénie est segmenté en Allemagne, en France, au Royaume-Uni, en Italie, en Espagne et dans le reste de l\'Europe. L’Europe occupe une position importante sur le marché mondial du traitement de la sarcopénie et devrait enregistrer un TCAC notable au cours de la période de prévision.

L\'Allemagne est un marché attractif en raison de son approche innovante en matière de soins de santé. Selon l\'Office fédéral de la statistique, les dépenses de santé dans ce pays se sont élevées à 474 milliards de dollars en 2021. La prise de conscience de la sarcopénie et de l\'obésité sarcopénique (OS) augmente progressivement dans les sociétés vieillissantes de toute l\'Allemagne. La sarcopénie et l\'OS sont relativement rares (<5 %) chez les hommes allemands âgés de 70 ans et plus. Par conséquent, une recrudescence des cas de troubles orthopédiques, associée à la demande croissante de suppléments nutritionnels, stimule la croissance du marché du traitement de la sarcopénie en Allemagne.

Revenus et prévisions du marché européen du traitement de la sarcopénie jusqu\'en 2030 (millions de dollars américains)

Segmentation du marché européen du traitement de la sarcopénie

Le marché européen du traitement de la sarcopénie est classé en type de traitement et en canal de distribution. , et le pays.

En fonction du type de traitement, le marché européen du traitement de la sarcopénie est segmenté en supplément de vitamine D et de calcium, supplément de protéines, supplément de vitamine B12 et autres. Le segment des suppléments de vitamine D et de calcium détenait la plus grande part de marché du traitement de la sarcopénie en Europe en 2022.

En termes de canal de distribution, le marché européen du traitement de la sarcopénie est segmenté en pharmacies, canaux de vente au détail, canaux en ligne et autres. Le segment des pharmacies détenait la plus grande part de marché du traitement de la sarcopénie en Europe en 2022.

Par pays, le marché européen du traitement de la sarcopénie est segmenté en Allemagne, en France, en Italie, au Royaume-Uni, en Espagne et dans le reste de l\'Europe. L\'Allemagne a dominé la part de marché du traitement de la sarcopénie en Europe en 2022.

Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc et Sanofi SA font partie des sociétés leaders opérant sur le marché européen du traitement de la sarcopénie.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Sarcopenia Treatment Market - Key Industry Dynamics

4.1 Europe Sarcopenia Treatment Market - Key Industry Dynamics

4.2 Market Drivers

4.2.1 Upsurge in Geriatric Population

4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults

4.3 Key Market Restraints:

4.3.1 Unavailability of Direct Interventions

4.4 Key Market Opportunities:

4.4.1 Products in Clinical Trial Phases

4.5 Future Trends:

4.5.1 Rising Awareness About Sarcopenia

4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Europe Market Analysis

5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

5.2 Europe Sarcopenia Treatment Market Forecast and Analysis

6. Europe Sarcopenia Treatment Market Analysis - By Treatment Type

6.1 Vitamin D and Calcium Supplement

6.1.1 Overview

6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.2 Protein Supplement

6.2.1 Overview

6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.3 Vitamin B12 Supplement

6.3.1 Overview

6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe Sarcopenia Treatment Market Analysis - By Distribution Channel

7.1 Pharmacies

7.1.1 Overview

7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

7.2 Retail Channels

7.2.1 Overview

7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.3 Online Channels

7.3.1 Overview

7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Sarcopenia Treatment Market - Country Analysis

8.1 Europe

8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

9.1 Overview

9.2 Growth Strategies in the Sarcopenia Treatment Market

9.3 Inorganic Growth Strategies

9.3.1 Overview

9.4 Organic Growth Strategies

9.4.1 Overview

10. Company Profiles

10.1 Abbott Laboratories

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Bayer AG

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Metagenics LLC

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Nestle Health Science SA

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Novartis AG

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Pfizer Inc

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Sanofi SA

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Amway Corp

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 GSK Plc

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

List of Tables

Table 1. Europe Sarcopenia Treatment Market Segmentation

Table 2. Sarcopenia Drug Under Clinical Development

Table 3. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)

Table 4. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type

Table 5. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel

Table 6. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country

Table 7. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 8. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 9. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 10. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 11. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 12. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 13. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 14. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 15. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 16. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 17. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 18. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market

Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market

Table 21. Glossary of Terms, Sarcopenia Treatment Market

List of Figures

Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

Figure 4. Europe Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030

Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 9. Europe Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030

Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)

Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 16. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 17. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 18. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 19. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 20. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 21. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 22. Growth Strategies in the Sarcopenia Treatment Market

1. Abbott Laboratories 
2. Amway Corp 
3. Bayer AG 
4. GSK Plc 
5. Metagenics LLC 
6. Nestle Health Science SA 
7. Novartis AG 
8. Pfizer Inc 
9. Sanofi SA 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sarcopenia treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sarcopenia treatment market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440